Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ARGX
#313
argenx SE - American Depositary Shares
817.9
9
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.85%
Monthly Change
-18.57%
6 month change
+2.25%
Year Change
+2.67%
Previous Close
825.0
3
Open
832.3
3
Low
811.9
0
High
832.3
8
Markets
US Stock Market
Healthcare
Biotechnology
ARGX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
47.57 M
51.67 M
55.4 M
59.19 M
60.76 M
61.88 M
61.88 M
Valuation ratios
Enterprise value
13.41 B
16.76 B
19.91 B
20.5 B
35.87 B
48.55 B
48.91 B
Price to earnings ratio
—
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
-0.14
-0.23
-0.06
0.13
0.15
—
Return on equity %
—
-0.16
-0.25
-0.07
0.15
0.18
—
Return on invested capital %
—
—
—
—
—
—
—
Gross margin %
—
—
-3.99
-0.74
-10.09
-2.49
—
Operating margin %
—
-64.65
-161.78
-33.51
-0.96
24.81
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
-75.69
-159.36
-23.26
36.99
30.41
—
Liquidity ratios
Quick ratio
—
8.08
8.42
9.01
6.68
4.87
—
Current ratio
—
8.44
9.18
9.75
7.29
5.23
—
Inventory turnover
—
—
0.17
0.44
0.63
1.02
—
Asset turnover
—
0.19
0.15
0.33
0.42
0.57
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
—
—
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
—
—
Working capital per share
—
—
—
—
—
—
—
Book value per share
—
—
—
—
—
—
—
News
Oppenheimer Maintains Outperform on argenx, Lowers Price Target to $1038
argenx Meets Primary Endpoint in Phase II Celiac Disease Study
Evercore ISI Group Maintains Outperform on argenx, Lowers Price Target to $1078
Baird Maintains Neutral on argenx, Lowers Price Target to $823
ARGX Stock Down on Stopping Late-Stage Autoimmune Disease Study
$100 Invested In argenx 5 Years Ago Would Be Worth This Much Today
ARGX Stock Sinks as Argenx Scraps Late-Stage Trial
Crude Oil Gains 5%; PepsiCo Posts Upbeat Q3 Earnings
HALO Wins Court Order Blocking Merck's Keytruda SC in Europe
Former Highflier Argenx Plummets On A Surprise Setback In Sjogren's
Argenx Halts Phase 3 Study in Rare Disease Following Futility Analysis
Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session